HILLSTREAM BIOPHARMA INC (HILS) Stock Analyst Earnings Estimates
NASDAQ:HILS - Nasdaq - US4327051011 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.424M | -1.808M -27.00% | -3.208M -77.40% | -6.882M -114.52% | N/A -9.44% | N/A 36.40% | N/A -1.00% | N/A -63.32% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A 35.90% | N/A 70.00% | N/A 33.33% | N/A -582.60% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.06 | -0.05 |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -1.734M 18.50% | -1.53M 13.39% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.16 | -0.16 | 0.00 | 1.96% |
| Q1 2023 Q2Q % growth | -0.23 | -0.11 | -0.12 | -104.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -13.64% |
| Revenue | N/A | N/A | N/A | N/A |